​NanoMicro at CPHI South East Asia 2026: Exploring Opportunities in a Rapidly Evolving Pharmaceutical Market

July 13, 2026 | Bangkok, Thailand

From July 8 to 10, 2026, NanoMicro participated in CPHI South East Asia 2026 at the Queen Sirikit National Convention Center in Bangkok, Thailand.

With more than 400 exhibitors, 10,000 attendees and participants from over 70 countries, the event brought together stakeholders across the ASEAN pharmaceutical supply chain, including API, biopharmaceuticals, contract manufacturing, herbal medicines and laboratory technologies.

Understanding a Diverse and Growing Market

Southeast Asia’s pharmaceutical industry is developing rapidly, while individual markets remain at different stages of maturity.

At CPHI SEA, natural extracts, herbal medicines and traditional pharmaceutical products remained highly visible, alongside growing interest in biopharmaceuticals, CDMO services and advanced pharmaceutical technologies.

This combination reflects a region where traditional pharmaceutical industries are evolving alongside new manufacturing and biotechnology capabilities.

Bringing Separation and Purification Technologies to ASEAN

NanoMicro presented chromatography media and related technologies for a broad range of separation and purification applications.

Together with SEPURE, NANOCHROM and FULI, the company demonstrated capabilities spanning chromatography media, protein purification, analytical chromatography and related technologies.

Customer discussions during the exhibition covered chromatography applications, purification technologies, OEM cooperation and distribution opportunities across Thailand, Vietnam, India and other markets.

Building Local Connections

One of the key observations from CPHI SEA was the importance of local relationships and technical support in the development of Southeast Asian markets.

For NanoMicro, international growth is therefore not simply about bringing products into new countries. It is about building partnerships with local distributors, customers and technical teams that can provide responsive support and understand regional requirements.

At the same time, the growing international presence of Chinese pharmaceutical and CDMO companies creates opportunities for NanoMicro to support customers as they expand into overseas markets.

Looking Ahead

Southeast Asia is not a single market, but a group of rapidly evolving pharmaceutical ecosystems.

NanoMicro will continue to strengthen its regional presence, develop local partnerships and explore opportunities in biopharmaceutical purification, analytical chromatography and other high-value applications.

As the pharmaceutical industry across ASEAN continues to develop, NanoMicro looks forward to working with customers and partners to support the region’s next stage of pharmaceutical growth.